Trial intelligence / Profile preview

Azelaic Acid Foam 15% in Papulopustular Rosacea

NCT01555463Phase 3Completed

Sponsor
LEO Pharma
Start
Sep 2012
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of azelaic acid 15% gel vehicle in papulopustular rosacea, sponsored by LEO Pharma. Started Sep 2012; status: completed.

02

Drugs

azelaic acid 15% gel vehicle
03

Conditions

papulopustular rosacea

Beyond the preview

Go deeper on NCT01555463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01555463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call